Related Experiment Videos
Examining developer perspectives on medical AI regulatory frameworks
Cameron M Choo1, Shelly Malik2,3, Mengling Feng4
1Interdisciplinary Graduate Programme (Neuroscience), Nanyang Technological University, Singapore, Singapore.
Abstract:
Regulatory frameworks ensure the trustworthiness of artificial intelligence in medicine (AI-MD). Yet, developers' perspectives on these frameworks remain underexplored. We surveyed 122 AI-MD developers online, examining their awareness, familiarity, and adoption of regulatory frameworks, alongside their views on ethical principles and stakeholder responsibilities. About half (57.4%, n = 70) were aware of any frameworks while reporting moderate familiarity. A third (33.6%, n = 41) indicated that their organizations had formally adopted such frameworks. Developers identified robustness as the most critical ethical principle and viewed themselves as primarily responsible for implementing regulatory standards. Independent t-tests indicated marginal and significant differences in awareness (p = 0.051) and familiarity (p < 0.001), respectively, between developers from adopting and non-adopting organizations. Senior and junior developers differed significantly on both measures (p < 0.05). These findings highlight developers' strong sense of professional accountability but also reveal limited familiarity and adoption, underscoring the need for greater education and organizational support to foster responsible AI-MD practices.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Control Governance: Regulatory Bodies and Their Impact
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Regulation
Standards of Care II
Global Regulatory Systems